Janney Montgomery Scott
DGX icon

Janney Montgomery Scott’s Quest Diagnostics DGX Stock Holding History

Janney Montgomery Scott’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Sell
21,482
-441
-2% -$85.7K 0.01% 918
2025
Q4 		$3.8M Buy
21,923
+760
+4% +$138K 0.01% 1028
2025
Q3 		$4.03M Buy
21,163
+1,021
+5% +$181K 0.01% 979
2025
Q2 		$3.62M Buy
20,142
+2,132
+12% +$370K 0.01% 945
2025
Q1 		$3.05M Buy
18,010
+1,566
+10% +$257K 0.01% 982
2024
Q4 		$2.48M Buy
16,444
+96
+0.6% +$14.9K 0.01% 1061
2024
Q3 		$2.54M Buy
16,348
+2,805
+21% +$419K 0.01% 1029
2024
Q2 		$1.85M Sell
13,543
-736
-5% -$101K 0.01% 1136
2024
Q1 		$1.9M Sell
14,279
-684
-5% -$88.7K 0.01% 1179
2023
Q4 		$2.06M Sell
14,963
-1,929
-11% -$254K 0.01% 1090
2023
Q3 		$2.06M Sell
16,892
-6,994
-29% -$932K 0.01% 1014
2023
Q2 		$3.36M Buy
23,886
+2,744
+13% +$378K 0.01% 844
2023
Q1 		$2.99M Buy
21,142
+313
+2% +$44.8K 0.01% 816
2022
Q4 		$3.26M Sell
20,829
-2,316
-10% -$333K 0.01% 820
2022
Q3 		$2.84M Buy
23,145
+304
+1% +$40K 0.01% 818
2022
Q2 		$3.12M Buy
22,841
+649
+3% +$88.4K 0.01% 739
2022
Q1 		$3.04M Sell
22,192
-385
-2% -$53.7K 0.01% 748
2021
Q4 		$3.91M Sell
22,577
-53,104
-70% -$8.08M 0.02% 699
2021
Q3 		$11M Buy
75,681
+3,856
+5% +$564K 0.05% 342
2021
Q2 		$9.48M Buy
71,825
+10,254
+17% +$1.34M 0.04% 382
2021
Q1 		$7.9M Buy
61,571
+45,950
+294% +$5.66M 0.04% 392
2020
Q4 		$1.86M Buy
15,621
+129
+0.8% +$15.7K 0.01% 911
2020
Q3 		$1.77M Buy
15,492
+1,826
+13% +$216K 0.01% 841
2020
Q2 		$1.56M Sell
13,666
-6,232
-31% -$661K 0.01% 860
2020
Q1 		$1.6M Buy
19,898
+5,256
+36% +$544K 0.01% 776
2019
Q4 		$1.56M Buy
14,642
+626
+4% +$65.3K 0.01% 882
2019
Q3 		$1.5M Buy
14,016
+4,674
+50% +$480K 0.01% 870
2019
Q2 		$951K Buy
9,342
+1,666
+22% +$160K 0.01% 1074
2019
Q1 		$690K Buy
7,676
+205
+3% +$17.8K 0.01% 1214
2018
Q4 		$622K Sell
7,471
-900
-11% -$84.4K 0.01% 1172
2018
Q3 		$903K Buy
8,371
+416
+5% +$45.6K 0.01% 1093
2018
Q2 		$875K Sell
7,955
-12
-0.2% -$1.25K 0.01% 1055
2018
Q1 		$799K Buy
7,967
+622
+8% +$63.7K 0.01% 1066
2017
Q4 		$723K Sell
7,345
-304
-4% -$28.8K 0.01% 1107
2017
Q3 		$716K Sell
7,649
-1,077
-12% -$114K 0.01% 1078
2017
Q2 		$970K Buy
8,726
+499
+6% +$52.8K 0.01% 891
2017
Q1 		$808K Sell
8,227
-1,790
-18% -$171K 0.01% 939
2016
Q4 		$921K Buy
10,017
+613
+7% +$52.8K 0.01% 805
2016
Q3 		$796K Buy
+9,404
New +$790K 0.01% 755
2016
Q2 		– Sell
-8,155
Closed -$583K – 778
2016
Q1 		$583K Sell
8,155
-2,808
-26% -$188K 0.02% 711
2015
Q4 		$780K Buy
10,963
+327
+3% +$22K 0.02% 633
2015
Q3 		$654K Buy
10,636
+4,479
+73% +$313K 0.02% 700
2015
Q2 		$446K Buy
6,157
+1,356
+28% +$100K 0.01% 1244
2015
Q1 		$369K Buy
4,801
+1,348
+39% +$96.5K 0.01% 1601
2014
Q4 		$232K Sell
3,453
-1,120
-24% -$70.7K ﹤0.01% 1896
2014
Q3 		$277K Buy
4,573
+877
+24% +$54K 0.01% 1725
2014
Q2 		$217K Buy
+3,696
New +$216K ﹤0.01% 1886

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Janney Montgomery Scott's DGX Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Quest Diagnostics (DGX) stake by 2% in Q1 2026, selling an estimated $85.7K and leaving 21,482 shares worth $4.21M. The position accounts for 0.01% of the portfolio, ranked #918.

Janney Montgomery Scott first reported a position in DGX in Q2 2014 and has held it in 47 quarters since. The position peaked at $11M in Q3 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Janney Montgomery Scott held 21,482 shares of Quest Diagnostics worth $4.21M as of Q1 2026.
  • Janney Montgomery Scott sold 441 Quest Diagnostics shares in Q1 2026, an estimated $85.7K.
  • Quest Diagnostics made up 0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #918 holding.
  • Janney Montgomery Scott first reported a position in Quest Diagnostics in Q2 2014 and has held it in 47 quarters since.
  • Janney Montgomery Scott's Quest Diagnostics position peaked at $11M in Q3 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.